| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |